|
Article Cited by others SPECIAL COMMUNICATION
SASLT guidelines: Update in treatment of Hepatitis C virus infection
Alghamdi Abdullah S, Alghamdi Mohammed, Sanai Faisal M, Alghamdi Hamdan, Aba-Alkhail Faisal, Alswat Khalid, Babatin Mohammed, Alqutub Adel, Altraif Ibrahim, Alfaleh Faleh
Year : 2016| Volume: 22| Issue : 8 | Page no: 25-57 | This article has been cited by | | 1 |
The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia |
|
| | Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi | | | Saudi Pharmaceutical Journal. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia |
|
| | AhmedSaqer Alotaibi, Nour Shamas, UmairUddin Ansari, FaisalM Sanai, Ali Alshahrani, AhmedIbrahim Fathelrahman, MohammedAli Aseeri | | | Journal of Pharmacy And Bioallied Sciences. 2021; 13(3): 317 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia |
|
| | Faisal M. Sanai, Mohammed Alghamdi, Ellen Dugan, Abduljaleel Alalwan, Waleed Al-Hamoudi, Faisal Abaalkhail, Nasser AlMasri, Devin Razavi-Shearer, Homie Razavi, Jonathan Schmelzer, Faleh Z. Alfaleh | | | Journal of Infection and Public Health. 2020; 13(11): 1715 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
